WE MAKE AQUACULTURE PROGRESS
- An important step for sustainable aquaculture in Vietnam
• ALPHA JECT ® Panga 2 has been approved by the Department of Animal Health and will be available for customers in Vietnam early 2017
• The vaccine protects against Edwardsiella ictaluri and Aeromonas hydrophila, bacterias causing significant losses in the Vietnamese pangasius industry
PHARMAQ and Zoetis leaders came together in Puerto Montt, Chile last week to celebrate and promote the launch of ALPHA JECT LiVac® SRS, an innovative vaccine that helps control Salmon Rickettsial Septicaemia (SRS) Syndrome.
Zoetis Completes Purchase of PHARMAQ, the Global Leader in Vaccines and Innovation for Health Products in Aquaculture
FLORHAM PARK, N.J. - November 10, 2015 - Zoetis Inc. (NYSE:ZTS) today announced that it has completed the purchase of PHARMAQ, the global leader in vaccines and innovation for health products in aquaculture, for a price of $765 million on a debt-free basis, having fulfilled all closing requirements.
Did you know...
Newsfeed delivered by Meltwater News. PHARMAQ is not to be held liable for any of its content nor possible incorrect information given.
Pharmaq organiza segundo workshop "SmoltVision”
Pharmaq organiza segundo Workshop SmoltVision
En Pucón: Pharmaq organiza segundo workshop “SmoltVision”
Ny analyse for påvisning av Tenacibaculum maritimum
ZOETIS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Global Farm Animal Healthcare Market
How to foster innovation in aquaculture
Verdensener på fiskehelse
Global Aquaculture Vaccines Market